Life expectancy in Maha went down 2.36 years during Covid-19
MUMBAI: With two million excess deaths during the Covid-19 years, the average life span in India took a hit, reversing the gradual upwards trend for the first time in five decades.
In Maharashtra, life expectancy went down by 2.36 years, with men bearing over six times the burden than women, an analysis of 2021 mortality data released by the government on May 7 by research scholars and a professor at the Indian Institute of Population Studies (IIPS) has revealed.
The analysis was conducted by PhD research scholars Chandan Kumar, Pravat Bhandari and Himanshu Jaiswal under the supervision of Suryakant Yadav, an assistant professor at IIPS.
'Men are more vulnerable to death from external factors,' said one of the people behind the analysis, which they plan to submit to journals. 'Men tend to work outside the home, and this increased their proximity with high-risk zones during the Covid years. They tended to go out to earn and get supplies more, increasing their risk of contracting Covid.'
Overall, the country saw a 1.6-year decline in life expectancy, falling from 70.4 years in 2019 to 68.8 years in 2021. Only three states, Rajasthan, Telangana, and Uttar Pradesh, escaped this with modest gains in life expectancy by 2021.
In this statistic too, men took the larger share—2.7 times that of women—of the dip. Their life span dropped 2.2 years, from 68.9 years to 66.7 years. Women, on the other hand, lived five months less on an average, from 72.1 years in 2019 to 71.5 years in 2021.
Other states too saw this trend. 'This pattern of greater life expectancy loss among males compared to females was evident across all the 22 states analysed, though its magnitude varied significantly across states,' says the report. 'In Andhra Pradesh, Maharashtra and Uttarakhand, the decline in life expectancy in males was greater than five times that of females. Conversely, Assam, Jammu and Kashmir, Rajasthan, and Uttar Pradesh exhibited the smallest gender differences, with losses in male life expectancy being less than 1.5 times than that of females.'
The report says that the decline in male life expectancy further widened India's gender gap in life expectancy in 2021—it increased by 3.2 years in 2021 from 2.8 years in the pre-pandemic period. This effectively erased the slow progress India had been making in life expectancy over the years, taking it back by eight years to the 2013 level when average life expectancy was 68.8 years.
'India took an average of five years to add a one-year increase in life expectancy,' says the analysis. 'Hence, a loss of 1.6 years in life expectancy at birth reveals that the gains made over the past decade during normal or pre-pandemic years were effectively erased during the Covid pandemic. In other words, the Covid pandemic has rolled India's progress in life expectancy back to that of almost a decade earlier.'
With the absence of death data of the years after 2021, it is yet to be seen at what pace life expectancy recovers. 'Several high-income countries have seen a quick rebound in the losses in life expectancy, successfully reversing the losses in the post-pandemic years,' said one of the study participants. 'They are advantaged, with better infrastructure and better regulation, and with work-from-home decreasing risk. But we too should be optimistic about the rate India will bounce back from the setback caused by Covid.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
35 minutes ago
- Mint
Indias biotech sector grew nearly fivefold in past decade: DBT Secretary
New Delhi, Jun 23 (PTI) India's biotechnology sector has expanded rapidly in the past decade, with its bioeconomy growing from USD 35.5 billion in 2014 to USD 165.7 billion in 2024, according to Rajesh S Gokhale, Secretary, Department of Biotechnology (DBT). He said the sector is now aiming for a USD 300 billion target by 2030, as scientific advances begin to translate into industrial and public health gains. "Biotechnology is no longer a fringe discipline, it's now a strategic driver for India's economic and health priorities," Gokhale said at a press conference highlighting 11 years of DBT's achievements. Among the standout initiatives is GenomeIndia, a nationwide effort to sequence the genomes of 10,000 individuals from 99 population groups, he said. The data, released earlier this year, is expected to inform personalised medicine and help researchers develop diagnostics tailored to Indian populations. Gokhale also highlighted India's first in-human gene therapy trial using a lentiviral vector for Severe Hemophilia A. India's vaccine response, Gokhale said, demonstrated the capacity of the DBT-backed innovation ecosystem. Under "Mission COVID Suraksha", five COVID-19 vaccines developed with DBT support received emergency approvals, including GEMCOVAC-19, the world's first thermostable mRNA vaccine. Other products include the intranasal COVID-19 vaccine and CERVAVAC, India's first indigenous quadrivalent HPV vaccine, now part of the National Immunization Programme, according to document shared at the briefing. Indian scientists contributed to decoding the complex genome of bread wheat, a global staple crop, and published a reference genome with 94 per cent coverage. Other research showed how Mycobacterium tuberculosis can infect liver cells and undermine TB treatment efficacy, while a study on taurine levels suggested amino acid may influence aging. Gokhale said India's biotech startup landscape has changed dramatically, with over 10,000 startups now in the sector, up from a few hundred a decade ago. Over 800 biotech products have emerged in this period. Through BIRAC, DBT has helped set up 95 bio-incubators across 21 states. Infrastructure investments include India's first dedicated biomanufacturing institute in Mohali and vaccine testing labs notified as Central Drug Laboratories. Speed breeding facilities have also been established to accelerate the development of climate-resilient crops. The BioE3 policy, approved by the Cabinet in 2024, is aimed at fostering high-performance biomanufacturing aligned with Net Zero targets.
Hindustan Times
an hour ago
- Hindustan Times
378 healthcare professionals to be deployed for Puri Rath Yatra: Minister
Bhubaneswar, In preparation for the upcoming Rath Yatra, the Odisha government has announced a series of health measures, including the deployment of 378 healthcare professionals and 265 hospital beds to ensure public safety during the annual religious event in Puri. 378 healthcare professionals to be deployed for Puri Rath Yatra: Minister Talking to reporters, Health and Family Welfare Minister Mukesh Mahaling said elaborate arrangements have been made to handle medical emergencies during the festival, which draws lakhs of devotees each year. Mahaling added that in addition to 378 doctors and para-medical staff, 69 first-aid centres and 74 ambulances will be kept ready for any emergencies. Given the recent outbreak of diarrhoea, the government has taken precautions to ensure the availability of safe drinking water and prevent the sale of stale food in the town. The additional 265 hospital beds include 15 ICU beds and 100 beds at the ANM Training Centre, while the Puri District Headquarters Hospital has reserved 68 beds, including general, burn, and ICU facilities. "I hope that the Rath Yatra will be conducted smoothly with the blessings of Lord Jagannath," the minister said. The District Headquarters Hospital has reserved 68 beds, including 50 general beds, 8 burn ward beds, and 10 ICU beds, an official statement of health department said. Additionally, 200 units of blood have been reserved while two minor operation theatres along with specialised dressing rooms have been set up to handle any medical emergencies, it said. For the first time, a team of doctors from AIIMS Bhubaneswar will be stationed at medical centres in Puri to provide additional support. Similarly, a specialised 10-bed air-conditioned heat stroke centre has been established at Talabania to address weather-related health issues. "Rigorous health monitoring and disease prevention measures are in place to maintain public health standards throughout the Ratha Yatra period," the statement further said. To curb outbreak of any water or food-borne disease, a total of eight food safety officers have been assigned. All 108 emergency ambulances will remain on high alert and operate along designated corridors with the support of NGO volunteers. To prevent disease outbreaks, eight food safety officers and three mobile surveillance teams have been deployed. So far, 494 kg of unhygienic food has been destroyed after 249 inspections of food establishments. The administration has also collected 84 food samples, 22 water samples, and conducted 10 stool culture tests and 82 water analyses. An extensive information, education, and communication campaign will be undertaken to promote public health awareness covering food safety, safe drinking water practices, hand washing and hygiene protocols, ORS usage, health programs, COVID-19 prevention measures, and Ayushman Bharat Program awareness, the statement said. A dedicated Ratha Yatra control room will operate round-the-clock throughout the festival period to coordinate all health-related activities and respond to emergencies. The control room can be reached at mobile number 91 6370560247 and landline number 06752-222175 for any medical assistance or information. This article was generated from an automated news agency feed without modifications to text.
Economic Times
5 hours ago
- Economic Times
Amazon, not the first, nor the last to attempt disruption. 5 diagnostics stocks: From downside forecast, to upside as high as 67%
Just a couple of weeks back, there were headlines about rising Covid cases in Southeast Asian countries. And alarm bells started ringing in India. Almost in step with this development, a domestic diagnostic stock again came into the limelight, with some reports mentioning how the company is getting ready for another surge in Covid. Fortunately, there was no surge of cases in India. And there certainly was no panic. So, it is probably good that FONT SIZE SAVE PRINT COMMENT
